Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s40264-020-01025-z http://scihub22266oqcxt.onion/10.1007/s40264-020-01025-z 33245507!7694584!33245507     free     free     free       Drug+Saf 2021 ; 44 (2): 255-257 Nephropedia Template TP {{tp|p=33245507|t=2021. Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19 |pdf=|usr=}}{{33245507}} gab.com Text Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19 JO: Drug Saf http://www.kidney.de/pget.php?&tw=1&pmid=33245507 #FOAvip ? Twit Text FOAVip Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19 ????Drug Saf http://www.kidney.de/pget.php?&tw=1&pmid=33245507 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33245507 #FOAvip English Wikipedia <ref>{{Cite pmid|33245507}}</ref> Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19 #MMPMID33245507 Marzolini C; Stader F; Leuppi-Taegtmeyer A; Stoeckle M; Battegay M; Sendi P Drug Saf 2021[Feb]; 44 (2): 255-257 PMID33245507show ga ? |*COVID-19 Drug Treatment[MESH] |*Drug-Related Side Effects and Adverse Reactions[MESH] |*Long QT Syndrome/chemically induced/diagnosis[MESH] |*Pharmaceutical Preparations[MESH] |Female[MESH] |Humans[MESH] |Lopinavir/adverse effects[MESH] |Male[MESH] |SARS-CoV-2[MESH]Sex Differences in Lopinavir Concentrations and Occurrence of Marked Q(epmc).pdf DeepDyve Pubget Overpricing